Teva Paid $300M Kickbacks Through Copay Groups, Feds Say
Teva Pharmaceuticals USA Inc. used two copay foundations to funnel more than $300 million in illegal kickbacks to Medicare patients using its multiple sclerosis drug, effectively subsidizing the treatment while steadily...To view the full article, register now.
Already a subscriber? Click here to view full article